BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 37686462)

  • 1. Salivary Chemical Barrier Proteins in Oral Squamous Cell Carcinoma-Alterations in the Defense Mechanism of the Oral Cavity.
    Kalló G; Bertalan PM; Márton I; Kiss C; Csősz É
    Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Expression of Tissue/Salivary Transgelin mRNA Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma (OSCC).
    Bu J; Bu X; Liu B; Chen F; Chen P
    Med Sci Monit; 2015 Aug; 21():2275-81. PubMed ID: 26242444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Salivary Mycobiome in a Cohort of Oral Squamous Cell Carcinoma Patients From Sudan Identifies Higher Salivary Carriage of
    Mohamed N; Litlekalsøy J; Ahmed IA; Martinsen EMH; Furriol J; Javier-Lopez R; Elsheikh M; Gaafar NM; Morgado L; Mundra S; Johannessen AC; Osman TA; Nginamau ES; Suleiman A; Costea DE
    Front Cell Infect Microbiol; 2021; 11():673465. PubMed ID: 34712619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network pharmacology and bioinformatics analysis on the underlying mechanisms of baicalein against oral squamous cell carcinoma.
    Tang B; Dong Y
    J Gene Med; 2023 Jun; 25(6):e3490. PubMed ID: 36843559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of MicroRNA-15a and MicroRNA-16-1 Salivary Level in Oral Squamous Cell Carcinoma Patients.
    Koopaie M; Manifar S; Lahiji SS
    Microrna; 2021; 10(1):74-79. PubMed ID: 33970852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation.
    Rai AK; Panda M; Das AK; Rahman T; Das R; Das K; Sarma A; Kataki AC; Chattopadhyay I
    Arch Microbiol; 2021 Jan; 203(1):137-152. PubMed ID: 32783067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
    Guo H; Li C; Su X; Huang X
    Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
    [No Abstract]   [Full Text] [Related]  

  • 8. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
    Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
    Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compositional and functional changes in the salivary microbiota related to oral leukoplakia and oral squamous cell carcinoma: a case control study.
    Lan Q; Zhang C; Hua H; Hu X
    BMC Oral Health; 2023 Dec; 23(1):1021. PubMed ID: 38115005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysine 2-hydroxyisobutyrylation proteomics reveals protein modification alteration in the actin cytoskeleton pathway of oral squamous cell carcinoma.
    Zhang Z; Xie H; Zuo W; Tang J; Zeng Z; Cai W; Lai L; Lu Y; Shen L; Dong X; Yin L; Tang D; Dai Y
    J Proteomics; 2021 Oct; 249():104371. PubMed ID: 34500091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased CSTA expression promotes lymphatic metastasis and predicts poor survival in oral squamous cell carcinoma.
    Wang Y; Wang L; Li X; Qu X; Han N; Ruan M; Zhang C
    Arch Oral Biol; 2021 Jun; 126():105116. PubMed ID: 33831734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of serum/salivary exosomal Alix in patients with oral squamous cell carcinoma.
    Nakamichi E; Sakakura H; Mii S; Yamamoto N; Hibi H; Asai M; Takahashi M
    Oral Dis; 2021 Apr; 27(3):439-447. PubMed ID: 32688445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of differentially expressed lncRNAs in the pathogenesis of oral squamous cell carcinoma.
    Zhang S; Tian L; Ma P; Sun Q; Zhang K; GuanchaoWang ; Liu H; Xu B
    Arch Oral Biol; 2015 Oct; 60(10):1581-7. PubMed ID: 26276270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma in a Taiwanese Population.
    Gleber-Netto FO; Yakob M; Li F; Feng Z; Dai J; Kao HK; Chang YL; Chang KP; Wong DT
    Clin Cancer Res; 2016 Jul; 22(13):3340-7. PubMed ID: 26847061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
    Zhang YY; Mao MH; Han ZX
    Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
    Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
    Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
    Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
    J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary Immunosuppressive Cytokines IL-10 and IL-13 Are Significantly Elevated in Oral Squamous Cell Carcinoma Patients.
    Aziz S; Ahmed SS; Ali A; Khan FA; Zulfiqar G; Iqbal J; Khan AA; Shoaib M
    Cancer Invest; 2015; 33(7):318-28. PubMed ID: 26046681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.
    Pereira CM; de Carvalho AC; da Silva FR; Melendez ME; Lessa RC; Andrade VCC; Kowalski LP; Vettore AL; Carvalho AL
    BMC Cancer; 2018 Feb; 18(1):193. PubMed ID: 29454310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.